End-Payors Again Denied Cert. In Niaspan Pay-For-Delay MDL
A Pennsylvania federal judge once again declined to certify a class of end-payors in their suit alleging improper pay-for-delay settlements between AbbVie and Teva Pharmaceuticals Industries aimed at barring generic forms...To view the full article, register now.
Already a subscriber? Click here to view full article